AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 29th, 2007 • Ameripath Inc • Services-medical laboratories • Florida
Contract Type FiledMarch 29th, 2007 Company Industry JurisdictionTHIS AMENDMENT TO EMPLOYMENT AGREEMENT (“Amendment”) is made effective as of this January 1, 2007 by and between AmeriPath, Inc., a Delaware corporation, (the “Company”) and Jeffrey A. Mossler, M.D. (the “Executive”).
INCREMENTAL FACILITY AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 29th, 2007 • Ameripath Inc • Services-medical laboratories • New York
Contract Type FiledMarch 29th, 2007 Company Industry JurisdictionThis Incremental Facility Amendment to Credit Agreement, dated as of September 27, 2006 (this “Amendment”), is entered into among Ameripath, Inc., a Delaware corporation (the “Borrower”), the Lenders signatory hereto and Wachovia Bank, National Association, in its capacity as administrative agent for the Lenders (in such capacity, the “Administrative Agent”), and amends the Credit Agreement dated as of January 31, 2006 (as amended to the date hereof and as the same may be further amended, supplemented or otherwise modified from time to time, the “Credit Agreement”) entered into among the Borrower, Ameripath Holdings, Inc., the Subsidiary Guarantors named therein, the institutions from time to time party thereto as Lenders (the “Lenders”), the Administrative Agent and the other agents and arrangers named therein. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement. The Lenders signatory hereto and the Lenders wh
EMPLOYMENT AGREEMENTEmployment Agreement • March 29th, 2007 • Ameripath Inc • Services-medical laboratories • Texas
Contract Type FiledMarch 29th, 2007 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is made and entered into effective as of November 13, 2006, (the “Effective Date”) by and between AMERIPATH, INC., a Delaware corporation (the “Company”), and PHILIP A. SPENCER (hereinafter, the “Executive”).